• Redefining Storage to Enable Digital Twins

    Bio-IT World | While the concept of digital twins is similar in life sciences to manufacturing, human bodies are significantly more complex than industrial machines and systems, amplifying the challenges surrounding data generation, management, and analysis. Making effective use of the data required to advance digital twin research creates immense infrastructure challenges.

    Jan 30, 2025

  • Follow the Money: Obesity, COPD, Universal AI for Biology

    Bio-IT World | January saw new company launches in COPD and small molecules, as well as investments targeting genetic engineering, epigenome editing, regenerative medicine, and more.

    Jan 29, 2025

  • GSK’s $1B Acquisition, Roche Licenses Gene Therapy, New Products, More

    Bio-IT World | 23andMe launches a new research offering after mass resignation by their board, new multi-omics tool from Enhanc3D Genomics, Absci and Owkin announce an AI partnership, a new cloud-based vivarium platform from Charles River, and more.

    Jan 28, 2025

  • Radio Frequencies Show Potential in Treating Alzheimer’s Disease

    Bio-IT World | Through a fortunate stroke of serendipity 15 years ago, researchers experimenting with a mouse model of Alzheimer’s disease found that radio frequency (RF) energy could improve cognitive health. It was not unlike the discovery of penicillin based on the unexpected appearance of a bacteria-killing mold in a petri dish.

    Jan 23, 2025

  • Mount Sinai Develops AI Prediction Tool for Cancer Patient Response to ICI Therapy

    Bio-IT World | Researchers at the Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSKCC), have developed SCORPIO, an artificial intelligence (AI) tool that can predict how well patients with cancer will respond to immune checkpoint inhibitor (ICI) therapy by analyzing routine blood tests and clinical data.

    Jan 22, 2025

  • PacBio at JPM: Portfolio Development, LDTs

    Bio-IT World | PacBio’s president Christian Henry gave the sequencing company’s 43rd Annual J.P. Morgan Healthcare Conference address last week. And while Oxford Nanopore and Illumina both doubled down on proteomics and a multi-omic future, Henry stayed focus on PacBio’s mission to enable the promise of genomics to better human health.

    Jan 21, 2025

  • Illumina at JPM: Multi-Omics, Constellation, Partnerships

    Bio-IT World | Jacob Thaysen gave Illumina’s annual presentation at the 43rd Annual J.P. Morgan Healthcare Conference yesterday, outlining Illumina’s early 2024 results and the vision for the future. Illumina is not focusing only on building sequencers and sequencing genomes. Thaysen outlined an M&A and partnership strategy focused on expanding the company’s addressable markets.

    Jan 16, 2025

  • Oxford Nanopore at JPM: A Proteomics-Genomics Thing of Beauty

    Bio-IT World | Gordon Sanghera, CEO, presented on behalf of Oxford Nanopore Technologies at the 43rd Annual J.P. Morgan Healthcare Conference this week in San Francisco. Sanghera led the major sequencing companies in position on the program, presenting on Monday a multi-omics and proteomics emphasis that was echoed throughout the week by other sequencing platform providers.

    Jan 15, 2025